|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Tamoxifen and endometrial thicknessFrom: art fougner, md (evsono@pipeline.com)Fri Nov 14 09:51:09 1997
At Fri, 14 Nov 1997, Marco A. Pelosi, III, MD wrote: > >At Fri, 14 Nov 1997, art fougner, md wrote: >> >>At Fri, 14 Nov 1997, Dr Naimish Patel wrote: >>> Dr. Pelosi actually the most common entity in our practice associated with Tamoxifen is endometrial polyp, many of which are not associated with bleeding. we have not to date ( knocking wood) had a case of carcinoma in any of these polyps. thought you'd be interested. art
-- art fougner, md SonoScan/Genetic Sciences forest hills, ny evsono@pipeline.com
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:25:23 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.